首页> 外文OA文献 >DNA-EIA to detect high and low risk HPV genotypes in cervical lesions with E6/E7 primer mediated multiplex PCR.
【2h】

DNA-EIA to detect high and low risk HPV genotypes in cervical lesions with E6/E7 primer mediated multiplex PCR.

机译:DNA-EIA用E6 / E7引物介导的多重PCR检测宫颈病变中的高风险和低风险HPV基因型。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Oncogenicity of human papillomavirus (HPV) DNA in premalignant and malignant uterine cervical diseases is mainly induced by E6/E7 open reading frame (ORF). The presence of an oncogenic HPV DNA may be a diagnostic marker for the detection of cytologically negative smears. AIMS: To evaluate an original polymerase chain reaction enzyme immunoassay (PCR-EIA) for the detection and typing of oncogenic and non-oncogenic HPV types. METHODS: The test was an original multiplex labelled PCR-EIA for the detection and typing of oncogenic and non-oncogenic HPV using three consensus sequence primers within the oncogenic E6/E7 ORF. One primer was dinitrophenyl (DNP) labelled and the DNP labelled amplimers could be further hybridised with specific biotinylated oligoprobes mixed in only two cocktails: oncogenic (16, 18, 31, 33, 35, 52, and 58) and non-oncogenic (6 and 11) HPV types in only two wells; then biotinylated oligoprobes were deposited in streptavidin-coated microplates. The PCR-EIA was validated on HPV plasmids (types 6, 11, 16, 18, 31, 35, 52, and 58) and used to evaluate cervical scrapes from 181 patients (median age 32 years) at high risk for cervical cancer. RESULTS: HPV were detected in the cervical scrapes of 88 of 181 patients (48.6%); nine with non-oncogenic HPV (5.0%) and 79 with oncogenic HPV (43.6%) including 29 coinfections with oncogenic and non-oncogenic HPV. The number of oncogenic HPV infections increased with the presence of high grade lesions: 95.8% of the cervical scrapes from patients with high grade lesions contained oncogenic HPV compared with 32.1% of the specimens from patients without any lesions detectable by colposcopy and/or by cytological examination of the cervical smears. Moreover, 60% of cervical scrapes exhibiting low grade lesions contained oncogenic HPV. CONCLUSIONS: This test is simple, specific, sensitive, safe, fast, reproducible, and easy to use in routine practice. Thus, it is possible to detect simultaneously on a simple cervical scrape, two kinds of HPV--oncogenic and non-oncogenic--in just two microplate wells with non-isotopic oligoprobes.
机译:背景:人类乳头瘤病毒(HPV)DNA在癌前和恶性宫颈癌中的致癌性主要由E6 / E7开放阅读框(ORF)诱导。致癌的HPV DNA的存在可能是检测细胞学阴性涂片的诊断标记。目的:评估用于检测和分类致癌和非致癌HPV类型的原始聚合酶链反应酶免疫测定(PCR-EIA)。方法:该测试为原始多重标记PCR-EIA,使用致癌E6 / E7 ORF内的三个共有序列引物对致癌和非致癌HPV进行检测和分型。一种引物是二硝基苯基(DNP)标记的,DNP标记的扩增子可以与仅混合在两种混合物中的特定生物素化寡核苷酸杂交:致癌(16、18、31、33、35、52和58)和非致癌(6 11)仅两口井中的HPV类型;然后将生物素化寡核苷酸沉积在链霉亲和素包被的微孔板中。 PCR-EIA在HPV质粒(6、11、16、18、31、35、52和58型)上进行了验证,并用于评估181例宫颈癌高危患者(中位年龄32岁)的宫颈刮擦。结果:181例患者中88例宫颈刮片中检测到HPV(占48.6%);其中非致癌HPV的9例(5.0%)和致癌HPV的79例(43.6%),包括29例致癌和非致癌HPV合并感染。伴随高级别病灶的致癌性HPV感染数量增加:高级别病灶患者的宫颈刮片中95.8%含有致癌性HPV,而阴道镜和/或细胞学检查未发现任何病灶的患者标本中有32.1%检查宫颈涂片。此外,60%表现出低等病变的宫颈碎片含有致癌性HPV。结论:该测试简单,特异,灵敏,安全,快速,可重复且易于在常规实践中使用。因此,仅需在两个带有非同位素寡聚探针的微孔板孔中,就可以在简单的宫颈刮擦上同时检测两种HPV(致癌和非致癌)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号